Sun Pharma Advanced Research Company Q1 net loss at Rs 2.51 crore

May 03, 2014 07:40 pm | Updated November 16, 2021 07:26 pm IST - New Delhi

The total income of the company declined to Rs. 42.57 crore during the first quarter, as compared to Rs. 71.83 crore in the same period of previous fiscal. File Photo

The total income of the company declined to Rs. 42.57 crore during the first quarter, as compared to Rs. 71.83 crore in the same period of previous fiscal. File Photo

Sun Pharma Advanced Research Company on Saturday reported a net loss of Rs. 2.51 crore for the first quarter ended March 31, 2014, mainly on account of increase in expenses during the period.

The company had posted a net profit of Rs. 44.04 crore during the same period of previous fiscal, Sun Pharma Advanced Research Company Ltd. (SPARC) said in a statement.

The total income of the company declined to Rs. 42.57 crore during the first quarter, as compared to Rs. 71.83 crore in the same period of previous fiscal.

The company’s expenses during the quarter rose by 78.43 per cent to Rs. 48.16 crore in the first quarter, as against Rs. 26.99 crore during the same period of previous fiscal.

SPARC was demerged from Sun Pharmaceutical Industries Ltd as a research and drug discovery company in 2007.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.